Hepatitis C Virus (HCV) is a global health problem necessitating novel measures. European scientists investigated how the virus affects the metabolic state of infected cells to promote replication and survival.
Hundreds of millions of people become infected with HCV every year. Because of the lack of a prophylactic vaccine and the limited therapies available, persistent HCV infection can lead to chronic hepatitis, cirrhosis and liver cancer. Accumulating evidence indicates that disease progression involves metabolic alteration of lipid biogenesis and homeostasis in the liver.
Further details: How HCV promotes replication?